Bank of New York Mellon’s Bicycle Therapeutics BCYC Stock Holding History

Bank of New York Mellon’s Portfolio BCYC Stock Details BCYC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-8,490	Closed	-$353K	–	4620
2021 Q3	$353K	Sell	8,490 -3,630	-30%	-$127K	﹤0.01%	3973
2021 Q2	$368K	Sell	12,120 -30	-0.2%	-$906	﹤0.01%	3908
2021 Q1	$363K	Sell	12,150 -1,120	-8%	-$28.9K	﹤0.01%	3839
2020 Q4	$238K	Buy	+13,270	New	+$256K	﹤0.01%	3920

Other funds holding BCYC

RCI

Ridgeback Capital Investments Miami Beach, Florida $560K AUM

TCM

Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Bank of New York Mellon's BCYC Position: Q4 2021 in Review

Bank of New York Mellon sold out of Bicycle Therapeutics (BCYC) in Q4 2021, closing a stake of 8,490 shares — an estimated $353K sold.

Bank of New York Mellon first reported a position in BCYC in Q4 2020 and held it in 4 quarters. The position peaked at $368K in Q2 2021. 101 funds tracked by Wall St. Rank hold BCYC as of Q4 2021.

Bank of New York Mellon reported no remaining Bicycle Therapeutics position as of Q4 2021 after selling out during the quarter.
Bank of New York Mellon sold 8,490 Bicycle Therapeutics shares in Q4 2021, an estimated $353K.
Bank of New York Mellon first reported a position in Bicycle Therapeutics in Q4 2020 and held it in 4 quarters.
Bank of New York Mellon's Bicycle Therapeutics position peaked at $368K in Q2 2021.
101 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q4 2021.

Based on Bank of New York Mellon's 13F filing for Q4 2021, filed 11 Feb 2022.